Skip to main content
Publications
Duran CE, Riera-Arnau J, Abtahi S, Pajouheshnia R , Hoxhaj V, Gamba M, Alsina E, Martin-Perez M, Garcia-Posa P, Llorente-Garcia A, Gonzalez-Bermejo D, Ibanez L, Sabate M, Vidal X, Ballarin E, Sanfelix-Gimeno G, Rodriguez-Bernal C, Peiro S, Garcia-Sempere A, Sanchez-Saez F, Lentile V, Ingrasciotta Y, Guarneri C, Tanaglia M, Tari M, Herings R, Houben E, Swart-Polinder K, Holthuis E, Huerta C, Gini R, Roberto G, Bartolini C, Paoletti O, Limoncella G, Girardi A, Hyeraci G, Andersen M, Kristiansen SB, Hallgreen CE, Klungel O, Sturkenboom M. Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis . Front Pharmacol. 2023 Aug 17;14:1207976. doi: 10.3389/fphar.2023.1207976
Abdulkareem NM, Bhat R, Powell RT, Chikermane S, Yande S , Trinh L, Abdelnasser HY, Tabassum M, Ruiz A, Sobieski M, Nguyen ND, Johnson M, Kaipparettu BA, Johnson CA, Bond RA, Stephan C, Triveni MV. Screening of GPCR drugs for repurposing in breast cancer . Front Pharmacol. 2022 Dec 6;13:1049640. doi: 10.3389/fphar.2022.1049640
Arana A , Margulis AV , McQuay LJ, Ziemiecki R , Bartsch JL , Rothman KJ , Franks B, D Silva M, Appenteng K, Varas-Lorenzo C, Perez-Gutthann S . Variation in cardiovascular risk related to individual antimuscarinic drugs used to treat overactive bladder: a cohort study in the UK . Pharmacotherapy. 2018 Jun;38(6):628-37. doi: 10.1002/phar.2121.
Kaye JA, Castellsague J, Bui CL , Calingaert B , McQuay LJ, Riera-Guardia N , Saltus CW , Quinlan S, Holick CN, Wahl PM, Suzart K, Rothman KJ , Wallander M-A, Perez-Gutthann S . Risk of acute liver injury associated with the use of moxifloxacin and other oral antimicrobials: a retrospective, population-based cohort study . Pharmacotherapy. 2014 Apr;34(4):336-49. doi: 10.1002/phar.1367